- Report
- February 2024
- 120 Pages
Global
From €4614EUR$4,750USD£3,980GBP
- Report
- November 2023
- 30 Pages
Global
From €3157EUR$3,250USD£2,723GBP
- Report
- June 2021
- 185 Pages
Global
From €4055EUR$4,175USD£3,498GBP
- Report
- August 2022
- 111 Pages
Global
From €4614EUR$4,750USD£3,980GBP
- Report
- April 2023
- 115 Pages
Global
From €4614EUR$4,750USD£3,980GBP
- Report
- July 2023
- 8 Pages
United States
From €510EUR$525USD£440GBP
- Report
- February 2022
- 75 Pages
Global
From €1943EUR$2,000USD£1,676GBP
- Report
- December 2021
- 57 Pages
Global
From €1894EUR$1,950USD£1,634GBP
- Report
- November 2018
- 36 Pages
Global
From €6216EUR$6,400USD£5,362GBP
- Report
- October 2022
- 64 Pages
Global
From €1943EUR$2,000USD£1,676GBP
- Report
- October 2022
- 182 Pages
Global
From €1943EUR$2,000USD£1,676GBP
- Report
- July 2022
- 51 Pages
Global
From €3399EUR$3,500USD£2,933GBP
- Report
- September 2022
- 71 Pages
Global
From €3399EUR$3,500USD£2,933GBP
- Report
- August 2022
- 104 Pages
Global
From €1943EUR$2,000USD£1,676GBP
- Report
- April 2022
- 413 Pages
Global
From €2428EUR$2,500USD£2,095GBP
- Book
- April 2018
- 224 Pages
The Rheumatology market is a subset of the Drug Discovery industry, focusing on the development of treatments for rheumatic diseases. These diseases are characterized by inflammation and pain in the joints, muscles, and other connective tissues. The market is driven by the need to develop new treatments for these conditions, as existing treatments are often inadequate. Companies in the market are researching and developing new drugs, biologics, and other therapies to address the unmet needs of patients.
The Rheumatology market is highly competitive, with many companies vying for a share of the market. Companies in the market include AbbVie, Amgen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Janssen, Merck, Novartis, Pfizer, and Roche. Show Less Read more
